{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:34:29Z","timestamp":1790026469831,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Melasma is a chronic, acquired disorder of focal hypermelanosis. It clinically presents as hyperpigmented patches over photo-exposed areas such as the face. The study aimed to evaluate the efficacy and safety of combined fractional CO2 laser with topical tranexamic acid (TA) versus combined fractional CO2 laser with topical ascorbic acid in treating patients with melasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty individuals, spanning the ages of 20 to 50, diagnosed with melasma were included in this prospective split-face comparison study. Patients were subjected to detailed medical, skin, dermoscopic, and Woods light, digital skin assessment for their grading of melasma before and after treatment. Subjects received fractional CO2 laser sessions to the affected areas before applying 10% solution of TA on the right side and 20% ascorbic acid solution on the left side.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline dermoscopic examination of the right side showed that 62.5% of the patients had fading of pseudo reticular network, 22.5% had fading telangiectasia, while the other 15% had no change. Considering the left side, 55% had fading of pseudo reticular network, 40% had fading telangiectasia, while the other 5% had no change. The baseline characteristics of melasma were comparable except for vascularity which was significantly higher in the right side compared to the left (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Trans-epidermal delivery of tranexamic acid or vitamin C after low power fractional CO2 laser is a useful tool with more superiority towards the tranexamic acid treatment. More controlled larger sample trials are required to establish an optimal and effective treatment for melasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s10103-025-04529-1","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:37:49Z","timestamp":1750034269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fractional carbon dioxide laser assisted delivery of tranexamic acid versus ascorbic acid in the treatment of melasma: a split face comparative study with digital skin analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Bayoumy I.","family":"Eassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed L.","family":"Elsaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"4","key":"4529_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/JCAS.JCAS_237_20","volume":"15","author":"J Batra","year":"2022","unstructured":"Batra J, Brar BK, Kumar S, Arora H (2022) Tranexamic acid in melasma: comparative evaluation of therapeutic efficacy of oral tranexamic acid versus its transepidermal administration. J Cutan Aesthet Surg 15(4):394\u2013399","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"4529_CR2","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/jocd.14953","volume":"21","author":"ES AboAlsoud","year":"2022","unstructured":"AboAlsoud ES, Eldahshan RM, AbouKhodair MH, Elsaie ML (2022) Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman\u2019s formula) in treating melasma: a randomized controlled study. J Cosmet Dermatol 21(6):2508\u20132515. https:\/\/doi.org\/10.1111\/jocd.14953","journal-title":"J Cosmet Dermatol"},{"issue":"47","key":"4529_CR3","doi-asserted-by":"publisher","first-page":"34996","DOI":"10.1039\/D4RA06266C","volume":"14","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Ma M, Chen Y, Xie H, Ding P, Zhang K (2024) Enhancing skin delivery of tranexamic acid via esterification: synthesis and evaluation of alkyl ester derivatives. RSC Adv 14(47):34996\u201335004","journal-title":"RSC Adv"},{"issue":"5","key":"4529_CR4","doi-asserted-by":"publisher","first-page":"e15376","DOI":"10.1111\/dth.15376","volume":"35","author":"MAM Abbas","year":"2022","unstructured":"Abbas MAM, Elgamal EEAE, Zaky MS, Elsaie ML (2022) Microneedling with topical vitamin C versus microneedling with topical insulin in the treatment of atrophic post-acne scars: a split-face study. Dermatol Ther 35(5):e15376. https:\/\/doi.org\/10.1111\/dth.15376","journal-title":"Dermatol Ther"},{"key":"4529_CR5","doi-asserted-by":"publisher","DOI":"10.1089\/photob.2024.0102","author":"SMA Ibrahim","year":"2025","unstructured":"Ibrahim SMA, Elsaie ML, Fusco I, Zingoni T, Rageh MA (2025) A 675 Nm laser in the treatment of facial melasma in dark skin types. Photobiomodul Photomed Laser Surg. https:\/\/doi.org\/10.1089\/photob.2024.0102","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"3","key":"4529_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/srt.12199","volume":"21","author":"AR Matias","year":"2015","unstructured":"Matias AR, Ferreira M, Costa P, Neto P (2015) Skin colour, skin redness and melanin biometric measurements: comparison study between antera 3D, mexameter and colorimeter. Skin Res Technol 21(3):346\u2013362","journal-title":"Skin Res Technol"},{"issue":"3","key":"4529_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/idoj.idoj_245_21","volume":"13","author":"A Navya","year":"2022","unstructured":"Navya A, Pai V (2022) Comparison of dermoscope and woods lamp as a tool to study melanin depth in melasma. Indian Dermatol Online J 13(3):366\u2013369. https:\/\/doi.org\/10.4103\/idoj.idoj_245_21","journal-title":"Indian Dermatol Online J"},{"key":"4529_CR8","doi-asserted-by":"publisher","first-page":"713554","DOI":"10.3389\/fmed.2021.713554","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu S, Wu H, Liang X, Guo D, Zhuo F (2021) Comparison of the efficacy of melasma treatments: a network meta-analysis of randomized controlled trials. Front Med (Lausanne) 8:713554","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"4529_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20164071","volume":"2","author":"KG Manjunath","year":"2016","unstructured":"Manjunath KG, Kiran C, Sonakshi S, Agrawal R, Melasma (2016) Through the eye of a dermoscope. Int J Res Dermatol 2(4):113\u2013117","journal-title":"Int J Res Dermatol"},{"issue":"3","key":"4529_CR10","first-page":"16","volume":"15","author":"T Rattananukrom","year":"2022","unstructured":"Rattananukrom T, Suchonwanit P, Thadanipon K, Vachiramon V (2022) A comparative study of dermatoscopic features of melasma and hori\u2019s nevus in Asian patients. J Clin Aesthet Dermatol 15(3):16\u201320","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"4529_CR11","first-page":"115","volume":"1","author":"C Tamler","year":"2009","unstructured":"Tamler C, Fonseca RMR, Pereira FBC, Barcau\u00ed CB (2009) Classification of melasma by dermoscopy: comparative study with wood\u2019s lamp. Surg Cosmet Dermatol 1(3):115\u2013119","journal-title":"Surg Cosmet Dermatol"},{"issue":"2","key":"4529_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/09546634.2020.1793888","volume":"33","author":"MA Atwa","year":"2022","unstructured":"Atwa MA, Ahmed AH, Nada HA, Refaey SM, Jafferany M, Elsaie ML (2022) Combined chemical peels versus trichloroacetic acid (TCA) for treating melasma: a split face study. J Dermatolog Treat 33(2):959\u2013964","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"4529_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jocd.12152","volume":"14","author":"M Banihashemi","year":"2015","unstructured":"Banihashemi M, Zabolinejad N, Jaafari MR, Salehi M, Jabari A (2015) Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol 14(3):174\u2013177","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"4529_CR14","first-page":"753","volume":"19","author":"B Ebrahimi","year":"2014","unstructured":"Ebrahimi B, Naeini FF (2014) Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci 19(8):753\u2013757","journal-title":"J Res Med Sci"},{"key":"4529_CR15","first-page":"309","volume":"6","author":"S Kondou","year":"2007","unstructured":"Kondou S (2007) Clinical study of effect of tranexamic acid emulsion on melasma and freckles. Skin Res 6:309\u2013315","journal-title":"Skin Res"},{"issue":"4","key":"4529_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/09546634.2015.1115812","volume":"27","author":"JY Chung","year":"2016","unstructured":"Chung JY, Lee JH, Lee JH (2016) Topical tranexamic acid as an adjuvant treatment in melasma: side-by-side comparison clinical study. J Dermatolog Treat 27(4):373\u2013377","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"4529_CR17","first-page":"626","volume":"32","author":"JH Lee","year":"2006","unstructured":"Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY et al (2006) Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 32(5):626\u2013631","journal-title":"Dermatol Surg"},{"issue":"3","key":"4529_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0974-2077.118403","volume":"6","author":"L Budamakuntla","year":"2013","unstructured":"Budamakuntla L, Loganathan E, Suresh DH, Shanmugam S, Suryanarayan S, Dongare A et al (2013) A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg 6(3):139\u2013143","journal-title":"J Cutan Aesthet Surg"},{"issue":"12","key":"4529_CR19","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1111\/jocd.14440","volume":"20","author":"MS Zaky","year":"2021","unstructured":"Zaky MS, Obaid ZM, Khalil EA, Elsaie ML (2021) Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: a split-face randomized study. J Cosmet Dermatol 20(12):4011\u20134016","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"4529_CR20","doi-asserted-by":"publisher","first-page":"e15211","DOI":"10.1111\/dth.15211","volume":"35","author":"R El-Husseiny","year":"2022","unstructured":"El-Husseiny R, Rakha N, Sallam M (2022) Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: a split-face comparative clinical, histopathological, and antera 3D camera study. Dermatol Ther 35(3):e15211. https:\/\/doi.org\/10.1111\/dth.15211","journal-title":"Dermatol Ther"},{"issue":"1","key":"4529_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.55519\/JAMC-01-9840","volume":"34","author":"MH Raza","year":"2022","unstructured":"Raza MH, Iftikhar N, Anwar A, Mashhood AA, Tariq S, Bin Hamid MA (2022) Split-face comparative analysis of microneedling with tranexamic acid vs vitamin C serum in melasma. J Ayub Med Coll Abbottabad 34(1):169\u2013172","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"5","key":"4529_CR22","first-page":"19","volume":"15","author":"V Gonz\u00e1lez-Molina","year":"2022","unstructured":"Gonz\u00e1lez-Molina V, Mart\u00ed-Pineda A, Gonz\u00e1lez N (2022) Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol 15(5):19\u201328","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"4529_CR23","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1002\/hsr2.537","volume":"5","author":"N Pazyar","year":"2022","unstructured":"Pazyar N, Molavi SN, Hosseinpour P, Hadibarhaghtalab M, Parvar SY, Dezfuly MB (2022) Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: a split-face comparative trial. Health Sci Rep 5(2):e537","journal-title":"Health Sci Rep"},{"key":"4529_CR24","first-page":"547","volume":"33","author":"S Gul","year":"2023","unstructured":"Gul S, Gardezi SAA, Arshad A, Ahmad TJ, Aman S, Shaukat S (2023) Microneedling with topical ascorbic acid in the treatment of melasma. J Pak Assoc Dermatol 33:547\u2013552","journal-title":"J Pak Assoc Dermatol"},{"issue":"3","key":"4529_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/09546634.2021.1871582","volume":"33","author":"AI Tahoun","year":"2022","unstructured":"Tahoun AI, Mostafa WZ, Amer MA (2022) Dermoscopic evaluation of tranexamic acid versus vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study. J Dermatolog Treat 33(3):1623\u20131629","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"4529_CR26","first-page":"63","volume":"16","author":"J Kaikati","year":"2023","unstructured":"Kaikati J, El Bcherawi N, Khater JA, Dib SM, Kechichian E, Helou J (2023) Combination topical tranexamic acid and vitamin C for the treatment of refractory melasma. J Clin Aesthet Dermatol 16(7):63\u201365","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"4529_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/DSS.0000000000003423","volume":"48","author":"SO Tawfic","year":"2022","unstructured":"Tawfic SO, Abdel Hay RM, Abouelazm DI, Said ER (2022) Tranexamic acid microinjection alone versus its combination with fractional carbon dioxide laser in melasma treatment: a dermoscopic evaluation. Dermatol Surg 48(5):556\u2013561","journal-title":"Dermatol Surg"},{"issue":"2","key":"4529_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jocd.13537","volume":"20","author":"KMM Mekawy","year":"2021","unstructured":"Mekawy KMM, Sadek A, Abdel-Hameed AKS (2021) Microneedling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study. J Cosmet Dermatol 20(2):460\u2013465","journal-title":"J Cosmet Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04529-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:22:12Z","timestamp":1771399332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04529-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04529-1","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by an ethics committee of Faculty of Medicine (Der_Med 93 Med Research) Al-Azhar University, Cairo; Egypt. This study was performed in accordance with the Declaration of Helsinki. All patients signed both Informed Consent Form and Consent for Image Use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"282"}}